3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
26
Urinary Bladder Neoplasms
17
Carcinoma, Non-Small-Cell Lung
17
Lung Neoplasms
13
Ovarian Neoplasms
10
Nasopharyngeal Carcinoma
9
Biliary Tract Neoplasms
8
Non-Muscle Invasive Bladder Neoplasms
7
Neoplasm Metastasis
7
Cholangiocarcinoma
7
Lymphoma, Large B-Cell, Diffuse
6
Triple Negative Breast Neoplasms
5
Colorectal Neoplasms
5
Breast Neoplasms
5
Recurrence
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Neoplasms
4
Fallopian Tube Neoplasms
4
Endometrial Neoplasms
4
Carcinoma, Transitional Cell
4
Osteosarcoma
3
Melanoma
3
Lymphoma, Non-Hodgkin
3
Uterine Cervical Neoplasms
2
Urologic Neoplasms
2
Rectal Neoplasms
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Gallbladder Neoplasms
2
Colonic Neoplasms
2
Interventions
Cisplatin
6
Paclitaxel
4
pembrolizumab
3
Fluorouracil
3
Carboplatin
3
tislelizumab
2
Taxes
2
Radiotherapy
2
Oxaliplatin
2
Leucovorin
2
Irinotecan
2
Injections
2
Capecitabine
2
130-nm albumin-bound paclitaxel
2
spartalizumab
1
lenvatinib
1
durvalumab
1
cixutumumab
1
apatinib
1
Tegafur
1
Surgical Procedures, Operative
1
Saline Solution
1
Radiation
1
Levoleucovorin
1
Laparoscopy
1
Histamine H2 Antagonists
1
Histamine Antagonists
1
Fulvestrant
1
Docetaxel
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
Gemcitabine
×
30 days
×
Clear all
No trials found.